Clinical Trial
doi: 10.1093/rheumatology/20.3.184.
Naproxen and sulindac in the treatment of osteoarthritis of the hip and knee
- PMID: 7025178
- DOI: 10.1093/rheumatology/20.3.184
Item in Clipboard
Clinical Trial
Naproxen and sulindac in the treatment of osteoarthritis of the hip and knee
Rheumatol Rehabil.
1981 Aug.
Abstract
Thirty patients with osteoarthritis of the hip or knee were entered into a double-blind, cross-over study of naproxen (750 mg/day) and sulindac (400 mg/day) both given in twice-daily regimens. Patients received each drug for four weeks. Both drugs produced improvements in the patients' overall condition. There were no statistically significant differences between the effects of the two drugs. There were few side-effects. Overall, both drugs proved beneficial and safe.
Similar articles
-
A multi-centre study of sulindac versus naproxen in the treatment of elderly osteoarthritic patients.Pharmatherapeutica. 1984;3(10):663-7. Pharmatherapeutica. 1984. PMID: 6379679 Clinical Trial.
-
Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis.Am J Med. 1986 Mar 24;80(3A):112-7. doi: 10.1016/0002-9343(86)90126-9. Am J Med. 1986. PMID: 3515919 Clinical Trial.
-
Sulindac versus piroxicam in the treatment of osteoarthritis.Curr Med Res Opin. 1983;8(6):434-40. doi: 10.1185/03007998309111750. Curr Med Res Opin. 1983. PMID: 6342958 Clinical Trial.
-
Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients.J Clin Pharmacol. 1989 Jun;29(6):524-8. doi: 10.1002/j.1552-4604.1989.tb03375.x. J Clin Pharmacol. 1989. PMID: 2666452 Clinical Trial.
-
[Comparison of the analgesic and anti-inflammatory effects of diclofenac, sulindac and naproxen. Multicentric double blind study].Prensa Med Mex. 1979 Jan-Feb;43(1-2):38-40. Prensa Med Mex. 1979. PMID: 398489 Clinical Trial. Spanish. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical